Skip to main contentSkip to navigation
Sirius Investors

MLOCT.PA Stock: Octopus Biosafety S.A. Stock Price, Analysis & Insights

Get live MLOCT.PA stock price $0.19, comprehensive Octopus Biosafety S.A. stock analysis, charts, news, and expert forecast. Real-time MLOCT.PA stock data and investment insights.

0.19
0.00%Today
MLOCT.PAOctopus Biosafety S.A. • Euronext Paris • Technology
Market Cap
23.77M
Volume
13.00K
52W High
0.50
52W Low
0.13

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

MCAI SAS, established in Cholet, France in 1987, focuses on creating, producing, and commercializing mobile, autonomous robots. These robotic systems are principally designed for sanitizing various facilities, such as aviation hubs, manufacturing pla...

Company Information

CEO
Bertrand Vergne
Sector
Technology
Industry
Computer Hardware
Employees
6

Contact Information

Address
29 rue Saint Pierre
Country
FR

Investment Analysis & Business Insights

Technology
Computer Hardware

Investment Highlights

Strong presence in the Technology sector with established market position

Lower volatility stock (Beta: 0.01) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Octopus Biosafety S.A. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Technology may affect company performance
  • Past performance does not guarantee future results for Octopus Biosafety S.A.
  • Investors should consider how Octopus Biosafety S.A. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

23.77M

P/E Ratio (TTM)

-4.67

Beta

0.01

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Technology Sector

The Technology sector includes companies that develop and provide technology products and services, including software, hardware, and digital solutions.

Technology (1D)

76/100 ⭐⭐⭐⭐⭐

Overall
+0.8%
NYSE
+0.7%
NASDAQ
+0.9%
Sector1D1W1MP/EScore
Financial Services+0.3%+1.3%+1.9%19.8
83/100⭐⭐⭐⭐⭐
Technology+0.8%+1.1%+3.0%52.0
76/100⭐⭐⭐⭐⭐
Basic Materials+0.8%+0.3%+1.9%27.9
69/100⭐⭐⭐⭐
Industrials-0.3%-0.9%+2.7%43.0
64/100⭐⭐⭐⭐
Communication Services-0.8%-1.3%+0.4%21.9
48/100⭐⭐⭐
Consumer Defensive+0.6%+1.6%-2.5%31.2
44/100⭐⭐⭐
Healthcare-1.0%-2.0%+1.5%30.5
43/100⭐⭐⭐
Real Estate+0.5%-1.1%-0.0%50.0
33/100⭐⭐
Energy+0.5%-3.6%-0.0%35.9
31/100⭐⭐
Utilities+2.0%-1.3%-5.1%26.1
31/100⭐⭐
Consumer Cyclical-0.3%+0.3%-0.2%55.8
28/100⭐⭐

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-13.